October 2007

• "Compliance with cGTPs/cGMPs in Manufacturing Cell and Gene Therapy Products"
  Scott R. Burger, MD
  Bureau of Food and Drug Analysis (BFDA) 2007 International Symposium on Regulation of Human Cell and Tissue-Based Products
  Taipei, Taiwan

• "Design, Operation and Management of GTP/GMP Cell Engineering Facilities"
  Scott R. Burger, MD
  Bureau of Food and Drug Analysis (BFDA) 2007 International Symposium on Regulation of Human Cell and Tissue-Based Products
  Taipei, Taiwan

• "Advanced Cell & Gene Therapy - Enabling Development and Commercialization of Cell and Gene Therapy Products"
  Scott R. Burger, MD
  Industrial Technology Research Institute (ITRI) - New Trends in Cell and Gene Therapy Meeting
  Hsinchu, Taiwan

June 2007

• "Technology Transfer: The First Step in Process Development"
  Scott R. Burger, MD
  Workshop session, International Society of Cell Therapy Annual Meeting
  Sydney, Australia

• "Preparation for Facility Inspections and Audits"
  Karen Edward
  Workshop session, International Society of Cell Therapy Annual Meeting
  Sydney, Australia

• "Characterization of Cell Therapy Products"
  Scott R. Burger, MD
  Technical session, International Society of Cell Therapy Annual Meeting
  Sydney, Australia

• "Benchmarking GTPs"
  Karen Edward
  Technical session, International Society of Cell Therapy Annual Meeting
  Sydney, Australia

May 2007

• "Manufacturing and Commercializing Cell Therapy Products"
  Scott R. Burger, MD
  NC BIO 2007
  Boston, MA

January 2007

• "Overcoming Comparability and Scale-up Challenges in Cell Therapy and Tissue Engineered Product Commercialization"
  Scott R. Burger, MD
  Phacilitate Cell & Gene Therapy Forum
  Baltimore, MD

October 2006

• "Product Characterization"
  Karen Edward
  AABB Annual Meeting
  Miami, Florida

September 2006

• "Translational Development: From Bench, to Clinic, to Commercial Manufacture"
  Scott R. Burger, MD
  IBC Life Sciences Gene Therapy Conference
  London, UK

• "Regulations and Standards for Cell Therapy - International Perspective"
  Scott R. Burger, MD
  Somatic Cell Therapy Annual Meeting
  Bethesda, MD

• "Product Release"
  Karen Edward
  Somatic Cell Meeting
  Bethesda, Maryland

• "Cell Therapy Products: Translational Development and Manufacturing"
  Scott R. Burger, MD
  Harvard Center for Human Cell Therapy
  Boston, MA

May 2006

• "Unrelated Product Quality Issues"
  Karen Edward
  ISCT Annual Meeting
  Berlin, Germany

• "Cell Therapy Product Characterization"
  Scott R. Burger, MD
  Technical Session, International Society for Cellular Therapy 2006 Annual Meeting
  Berlin, Germany

February 2006

• "Manufacturing Cell and Gene Therapy Products"
  Scott R. Burger, MD
  Center for the Engineering of Living Tissues, Georgia Institute of Technology/Emory University
  Atlanta, GA

January 2006

• "Options for Manufacturing Cell Therapy Products"
  Scott R. Burger, MD
  Speaker and session chair, Phacilitate Cell & Gene Therapy Forum 2006
  Baltimore, MD

November 2005

• "Characterization of Stem Cell Therapy Products"
  Scott R. Burger, MD
  IBC Stem Cell Research Challenges
  La Jolla, CA

October 2005

• "Donor Eligibility Final Rule"
  Karen Edward
  AABB Annual Meeting
  Seattle, WA

August 2005

• "Manufacturing Cell and Gene Therapy Products: Overcoming the Obstacles"
  Scott R. Burger, MD
  Cambridge Healthtech Institute Stem Cell Research Conference
  Cambridge, MA

June 2005

• "Regulatory Pathway for Cell Therapy Products. Stem Cells for Treatment of Neurological Diseases"
  Scott R. Burger, MD
  BIO 2005 Annual Meeting
  Philadelphia, PA

• "Manufacturing Cell Therapy Products - Challenges and Opportunities"
  Scott R. Burger, MD
  GE Healthcare Cell Technologies Science Programme
  Uppsala, Sweden

May 2005

• "Steps Toward Compliance - Laboratory Practices and Regulatory Affairs Workshop"
  Scott R. Burger, MD
  International Society for Cellular Therapy 2005 Annual Meeting
  Vancouver, BC

• "Developing Cell Therapy Product Manufacturing: Avoiding The Pitfalls"
  Scott R. Burger, MD
  International Society for Cellular Therapy 2005 Annual Meeting
  Vancouver, BC

February 2005

• "Strategies for Manufacturing Cell Therapy Products"
  Scott R. Burger, MD
  Johnson & Johnson Cell Therapy and Regenerative Medicine Task Force
  New Brunswick, New Jersey

January 2005

• "Commercialization of Cell and Gene Therapy Products: When and How?"
  Scott R. Burger, MD
  Phacilitate Cell and Gene Therapy Forum
  Washington, DC